The Global Low-Density Lipoprotein (LDL) Test market is currently at a pivotal juncture, transitioning from a routine diagnostic procedure to a cornerstone of precision cardiovascular medicine. As of 2024, the market is valued at 1.46 USD Billion and is projected to experience a robust expansion, reaching 2.56 USD Billion by 2032. This growth, characterized by...